Overview of registries, HLA typing and diversity, and search algorithms.

PubWeight™: 0.99‹?› | Rank: Top 15%

🔗 View Article (PMID 17445151)

Published in Tissue Antigens on April 01, 2007

Authors

C K Hurley1, M Maiers, S G E Marsh, M Oudshoorn

Author Affiliations

1: Georgetown University, Washington, DC 20057, USA. hurleyc@georgetown.edu

Articles by these authors

Nomenclature for factors of the HLA system, 2010. Tissue Antigens (2010) 3.22

New HLA haplotype frequency reference standards: high-resolution and large sample typing of HLA DR-DQ haplotypes in a sample of European Americans. Tissue Antigens (2003) 1.81

Monitoring the international use of unrelated donors for transplantation: the WMDA annual reports. Bone Marrow Transplant (2010) 1.60

The probability of finding a suitable related donor for bone marrow transplantation in extended families. Blood (1996) 1.52

HLA-DR4 is associated with a diminished risk of the development of chronic myeloid leukemia (CML). Chronic Leukemia Working Party of the European Blood and Marrow Transplant Registry. Leukemia (2000) 1.49

A community standard for immunogenomic data reporting and analysis: proposal for a STrengthening the REporting of Immunogenomic Studies statement. Tissue Antigens (2011) 1.31

Diverging effects of HLA-DPB1 matching status on outcome following unrelated donor transplantation depending on disease stage and the degree of matching for other HLA alleles. Leukemia (2009) 1.29

Common and well-documented HLA alleles: 2012 update to the CWD catalogue. Tissue Antigens (2013) 1.22

The HLA dictionary 2008: a summary of HLA-A, -B, -C, -DRB1/3/4/5, and -DQB1 alleles and their association with serologically defined HLA-A, -B, -C, -DR, and -DQ antigens. Tissue Antigens (2009) 1.15

A bioinformatics approach to ascertaining the rarity of HLA alleles. Tissue Antigens (2009) 1.15

Availability of unrelated donors for hematopoietic stem cell transplantation for hemoglobinopathies. Bone Marrow Transplant (2003) 1.14

Isolated HLA-C mismatches in unrelated donor transplantation for CML. Bone Marrow Transplant (2004) 1.12

Highly diverged MHC class I mismatches are acceptable for haematopoietic stem cell transplantation. Bone Marrow Transplant (2007) 1.12

How to improve the search for an unrelated haematopoietic stem cell donor. Faster is better than more! Bone Marrow Transplant (2005) 1.11

Human KIR sequences 2003. Immunogenetics (2003) 1.10

Genotype List String: a grammar for describing HLA and KIR genotyping results in a text string. Tissue Antigens (2013) 1.09

Identification by random forest method of HLA class I amino acid substitutions associated with lower survival at day 100 in unrelated donor hematopoietic cell transplantation. Bone Marrow Transplant (2011) 1.04

The quest for a bone marrow donor--optimal or maximal HLA matching? N Engl J Med (1998) 1.04

Minimal phenotype panels. A method for achieving maximum population coverage with a minimum of HLA antigens. Hum Immunol (1996) 1.02

HLA-A, B, C, DR and DQ polymorphisms in three South African population groups: South African Negroes, Cape Coloureds and South African Caucasoids. Tissue Antigens (1988) 1.02

World Marrow Donor Association guidelines for use of HLA nomenclature and its validation in the data exchange among hematopoietic stem cell donor registries and cord blood banks. Bone Marrow Transplant (2007) 1.01

World Marrow Donor Association framework for the implementation of HLA matching programs in hematopoietic stem cell donor registries and cord blood banks. Bone Marrow Transplant (2010) 1.00

Inhibition of human immunodeficiency virus type 1 replication in human mononuclear blood cells by the iron chelators deferoxamine, deferiprone, and bleomycin. J Infect Dis (2000) 0.99

Cost analysis of HLA-identical sibling and voluntary unrelated allogeneic bone marrow and peripheral blood stem cell transplantation in adults with acute myelocytic leukaemia or acute lymphoblastic leukaemia. Bone Marrow Transplant (2002) 0.99

An update to HLA nomenclature, 2010. Bone Marrow Transplant (2010) 0.96

Scoring for HLA matching? A clinical test of HistoCheck. Bone Marrow Transplant (2004) 0.96

Hematopoietic stem cell donor registry strategies for assigning search determinants and matching relationships. Bone Marrow Transplant (2004) 0.95

High-resolution molecular characterization of the HLA class I and class II in the Tarahumara Amerindian population. Tissue Antigens (2006) 0.92

Anti-HIV effect of iron chelators: different mechanisms involved. J Clin Virol (2001) 0.92

Validation of haplotype frequency estimation methods. Hum Immunol (1998) 0.91

Going back to the roots: effective utilisation of HLA typing information for bone marrow registries requires full knowledge of the DNA sequences of the oligonucleotide reagents used in the testing. Tissue Antigens (2000) 0.91

Guidelines for nomenclature usage in HLA reports: ambiguities and conversion to serotypes. Eur J Immunogenet (2002) 0.91

Information technology and the role of WMDA in promoting standards for international exchange of hematopoietic stem cell donors and products. Bone Marrow Transplant (2010) 0.91

Activated gelatinase-B (MMP-9) and urokinase-type plasminogen activator in synovial fluids of patients with arthritis. Correlation with clinical and experimental variables of inflammation. J Rheumatol (1995) 0.90

KIR gene in ethnic and Mestizo populations from Mexico. Hum Immunol (2006) 0.90

Translating the HLA-DPB1 T-cell epitope-matching algorithm into clinical practice. Bone Marrow Transplant (2013) 0.89

Cloning and sequencing full-length HLA-B and -C genes. Tissue Antigens (2003) 0.89

16(th) IHIW: extending the number of resources and bioinformatics analysis for the investigation of HLA rare alleles. Int J Immunogenet (2012) 0.89

A single nomenclature and associated database for alleles at the major histocompatibility complex class II DRB1 locus of sheep. Tissue Antigens (2011) 0.89

Eleven million donors in Bone Marrow Donors Worldwide! Time for reassessment? Bone Marrow Transplant (2007) 0.87

HLA gene haplotype frequencies in bone marrow donors worldwide registries. Hum Immunol (1997) 0.87

16(th) IHIW: global analysis of registry HLA haplotypes from 20 million individuals: report from the IHIW Registry Diversity Group. Int J Immunogenet (2012) 0.87

HLA gene and haplotype frequencies in Dutch blood donors. Tissue Antigens (1996) 0.86

Genetic differentiation of Jewish populations. Tissue Antigens (2010) 0.86

The HLA Dictionary 2004: a summary of HLA-A, -B, -C, -DRB1/3/4/5 and -DQB1 alleles and their association with serologically defined HLA-A, -B, -C, -DR and -DQ antigens. Int J Immunogenet (2005) 0.86

The HLA Dictionary 2004: a summary of HLA-A, -B, -C, -DRB1/3/4/5 and -DQB1 alleles and their association with serologically defined HLA-A, -B, -C, -DR and -DQ antigens. Tissue Antigens (2005) 0.85

Haplotype associations of 90 rare alleles from the National Marrow Donor Program. Tissue Antigens (2006) 0.85

Four-locus high-resolution HLA typing in a sample of Mexican Americans. Tissue Antigens (2009) 0.84

A special report: suggested procedures for international unrelated donor search from the donor registries and quality assurance working groups of the World Marrow Donor Association (WMDA). Bone Marrow Transplant (2004) 0.84

Predictive impact of allele-matching and EBMT risk score for outcome after T-cell depleted unrelated donor transplantation in poor-risk acute leukemia and myelodysplasia. Leukemia (2011) 0.84

Polymorphisms in the TNFA gene promoter region show evidence of strong linkage disequilibrium with HLA and are associated with delayed neutrophil engraftment in unrelated donor hematopoietic stem cell transplantation. Tissue Antigens (2004) 0.84

The impact of frequent HLA haplotypes in high linkage disequilibrium on donor search and clinical outcome after unrelated haematopoietic SCT. Bone Marrow Transplant (2012) 0.83

Human immunodeficiency virus type 1 replication inhibition by the bidentate iron chelators CP502 and CP511 is caused by proliferation inhibition and the onset of apoptosis. Eur J Clin Invest (2002) 0.83

Comparative validation of computer programs for haplotype frequency estimation from donor registry data. Tissue Antigens (2013) 0.83

16(th) IHIW: immunogenomic data-management methods. report from the immunogenomic data analysis working group (IDAWG). Int J Immunogenet (2012) 0.82

The HLA Dictionary 2001: a summary of HLA-A, -B, -C, -DRB1/3/4/5 and -DQB1 alleles and their association with serologically defined HLA-A, -B, -C, -DR and -DQ antigens. Eur J Immunogenet (2001) 0.82

Validation of large data sets, an essential prerequisite for data analysis: an analytical survey of the Bone Marrow Donors Worldwide. Tissue Antigens (1996) 0.82

The HLA genetic constitution of the Bushmen (San). Hum Immunol (1990) 0.82

The degree of matching at HLA-DPB1 predicts for acute graft-versus-host disease and disease relapse following haematopoietic stem cell transplantation. Bone Marrow Transplant (2003) 0.82

The HLA dictionary 1999: a summary of HLA-A, -B, -C, -DRB1/3/4/5, -DQB1 alleles and their association with serologically defined HLA-A, -B, -C, -DR and -DQ antigens. Tissue Antigens (1999) 0.82

Polymorphism of DRw52 and its association with DRw11 and DRw12 in South African blacks (Negroes) and individuals of mixed ancestry (Cape coloreds). Hum Immunol (1990) 0.81

An update to the HLA Nomenclature Guidelines of the World Marrow Donor Association, 2012. Bone Marrow Transplant (2013) 0.81

Large-scale DNA-based typing of HLA-A and HLA-B at low resolution is highly accurate specific and reliable. Tissue Antigens (2000) 0.81

The HistoCheck algorithm does not predict T-cell alloreactivity in vitro. Bone Marrow Transplant (2005) 0.81

A special report: histocompatibility testing guidelines for hematopoietic stem cell transplantation using volunteer donors. Tissue Antigens (1999) 0.81

Validation of statistical imputation of allele-level multilocus phased genotypes from ambiguous HLA assignments. Tissue Antigens (2014) 0.80

HLA-B8 and HLA-A3 coexpressed with HLA-B8 are associated with a reduced risk of the development of chronic myeloid leukemia. The Chronic Leukemia Working Party of the EBMT. Blood (1999) 0.80

The HLA dictionary 1999: a summary of HLA-A, -B, -C, -DRB1/3/4/5, -DQB1 alleles and their association with serologically defined HLA-A, -B, -C, -DR, and -DQ antigens. Hum Immunol (1999) 0.79

No impact of NOD2/CARD15 on outcome after SCT: a reply. Bone Marrow Transplant (2008) 0.79

Restriction fragment length polymorphism of HLA-DRw53 detected in South African blacks and individuals of mixed ancestry. Hum Immunol (1989) 0.79

The HLA dictionary 2001: a summary of HLA-A, -B, -C, -DRB1/3/4/5, -DQB1 alleles and their association with serologically defined HLA-A, -B, -C, -DR, and -DQ antigens. Hum Immunol (2001) 0.79

HLA frequencies in black Zimbabweans. Tissue Antigens (1990) 0.79

The HLA Dictionary 2001: a summary of HLA-A, -B, -C, -DRB1/3/4/5, -DQB1 alleles and their association with serologically defined HLA-A, -B, -C, -DR and -DQ antigens. Tissue Antigens (2001) 0.79

The World Marrow Donor Association (WMDA): its goals and activities. Bone Marrow Transplant (2003) 0.78

Further polymorphism of the MICA gene. Eur J Immunogenet (2002) 0.78

Clinical importance of HLA-DPB1 in haematopoietic cell transplantation. Tissue Antigens (2007) 0.78

The importance of identifying a back-up donor for unrelated stem cell transplantation. Bone Marrow Transplant (2005) 0.78

Cloning and sequencing alleles of the KIR2DL4 gene from genomic DNA samples. Tissue Antigens (2007) 0.78

Extensive haplotype diversity in African American mothers and their cord blood units. Tissue Antigens (2012) 0.77

Cross-reactive group matching does not lead to a better allocation and survival of donor kidneys. Transplantation (2000) 0.77

Unrelated donor marrow transplantation in children: transplant policy and outcome in Leiden Paediatrics SCT-Centre. Bone Marrow Transplant (2009) 0.77

16th International HLA and Immunogenetics Workshop (IHIW) Introduction. Int J Immunogenet (2012) 0.77

Permissible and immunogenic HLA-A mismatches: cytotoxic T-cell precursor frequencies reflect graft survival data. Hum Immunol (2001) 0.77

A special report: histocompatibility testing guidelines for hematopoietic stem cell transplantation using volunteer donors. Quality Assurance and Donor Registries Working Groups of the World Marrow Donor Association. Hum Immunol (1999) 0.77